Incorporating Treatment Guidelines and Patient Preference into Management of Rheumatoid Arthritis

Program Overview

Tight control of rheumatoid arthritis (RA) disease activity requires frequent disease monitoring and adjustment of therapy, as often as every 3 to 6 months. Unfortunately, the American College of Rheumatology (ACR) recommendations are sometimes not followed in clinical practice, particularly the use of disease activity measures, the application of treat-to-target recommendations, and the implementation of ACR treatment algorithms, leading to suboptimal patient care. This series of patient visit scenarios will allow you to make management decisions, benchmark your scores against those of your peers, and hear from experts in the field.

Credit Expired

CE Credit Expired

Target Audience

The target audience for this activity is physicians, nurse practitioners, and physician assistants who specialize in rheumatology and internal medicine.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Incorporate guideline-recommended disease activity measures into clinical practice
Select individualized treatments for patients with rheumatoid arthritis (RA) that maximize the opportunity to achieve remission and avoid relapse while minimizing toxicity
Employ a strong patient-provider collaborative approach to managing patients with RA that includes patient education, engagement, and shared decision making

Activity Faculty

Jeffrey R. Curtis, MD, MS, MPH

William J. Koopman Endowed Professor, Rheumatology and Immunology
Director, UAB Arthritis Clinical Intervention Program
Co-Director, UAB Center for Education and Research on Therapeutics
(CERTS) of Musculoskeletal Disorders
Co-Director, UAB PharmacoEpidEmiology and phaRmcoeconomics (PEER) Unit
University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology
Birmingham, AL

Martin Jan Bergman, MD, FACR, FACP, FCPP

Clinical Associate Professor, Medicine
Drexel University School of Medicine
Philadelphia, PA

Iris Navarro-Millán MD, MSPH

Assistant Professor, Division of General Internal Medicine
Hospital for Special Surgery
Division of Rheumatology
Weill Cornell Medicine
New York, NY

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Featured RMEI CE Activities

Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care

Closing the Gap: Personalized Approaches to Cervical Cancer Screening and Treatment

Privacy | Terms of Use